The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their weight loss drugs at a lower price through TrumpRx , sources familiar with the talks told ABC News.

Under the pending agreements, a month's supply of the drugs would cost roughly $149 and be covered for some Medicare beneficiaries, one source told ABC News.

Discussions between the pharmaceutical companies and the administration are still ongoing, the sources said. If an agreement is reached, an announcement is expected as soon as this week, according to the sources.

Endpoint News, an industry publication, first reported that the administration was nearing deals with the pharmaceutical giants.

White House deputy press secretary Kush Desai

See Full Page